These five optimisations can impact supply chain resilience for the better, helping your company withstand stress and recover from external shocks faster.
We explore five areas within the pharmaceutical supply chain where artificial intelligence (AI) can enable and build resilience.
Recent events have highlighted existing problems with supply chain resilience, but an often-missed consideration is the damage caused by cyber attacks.
Recent chaos caused by Brexit has been well-reported. While supply chain disruptions may seem unavoidable, using AI in supply chains may be the solution.
7bridges is proud to join the PwC Scale Consumer Markets Programme, to enable more businesses to rewire their supply chains.
The first instalment of the Supply Chain Leaders Series, hosted by 7bridges, the AI-powered Logistics Platform featuring Sam Herbert, COO of Clinigen Group
7bridges is leveraging the power of artificial intelligence (AI) to improve how pharmaceutical companies manage their supply chains. With its innovative platform, 7bridges aims to provide insights, enhanced decision-making capabilities, and optimisation opportunities that promise to reshape the industry landscape.
Accurate, objective and transparent data will help you achieve granular visibility, better rates, shorter timelines and optimised deliverables
It has been an unfortunate feature of UK health policy in recent years that concerted nationwide vaccine rollouts have been both frequent and necessary. The COVID-19 pandemic highlighted how central vaccines can be for our protection, and therefore how critical a smooth, on time distribution process is.
